Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $515 to $618.
Goldman Sachs Maintains Neutral on D.R. Horton, Lowers Price Target to $83
Goldman Sachs maintains D.R. Horton (NYSE:DHI) with a Neutral and lowers the price target from $120 to $83.